Zenas Biopharma (ZBIO) PT Lowered to $48 at Jefferies, 'we see clear path for approval (BLA submission planned in 2Q and MAA in 2H26')
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St on pace for higher open as oil pulls back ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NASDAQ: ZBIO) | Delayed: 27.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.24 | 52 Week High | $50.95 | |||
| Open | $27.24 | 52 Week Low | $18.06 | |||
| Day High | $27.24 | P/E | N/A | |||
| Day Low | $27.24 | EPS | $0.00 | |||
| Volume | 381,320 | |||||
